Komori
Other Disclosures190AChordia Therapeutics Inc.Pharmaceuticals

Speaking at the 4th Joint Seminar on Pharmaceuticals, Biotechnology and Healthcare

The Representative Director announced that they will speak at the Joint Pharmaceutical, Biotech and Healthcare Seminar scheduled for 8 July 2026. The seminar will be held online, and investors may also participate by registering in advance.

Worth reading
37Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

4th Joint Pharmaceutical, Biotech and Healthcare Seminar
Applicable field (uses covered by this announcement)

Pharmaceutical, biotech and healthcare industries, particularly the biotech sector

Launch dateScheduled for 8 July 2026 (speaking time: 18:50–19:15)
Relationship between the counterparty and the company
Chordia Therapeutics Inc.190A
Relationship with the Company

Our Representative Director will speak at the seminar hosted by the other party. Capital, personnel and business relationships: not disclosed

CounterpartyNxera Pharma Co.,Ltd.

Organizer of the seminar, which aims to promote activity in the pharmaceutical, biotech and healthcare industries, particularly the biotech sector. Other company details: not disclosed

Location (as indicated in this announcement)

Fujisawa, Kanagawa Prefecture (the company's head office)

Offering price

Free of charge

The company does not address Contract Value / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services Covered4th Joint Pharmaceutical, Biotech and Healthcare Seminar
CounterpartyNxera Pharma Co.,Ltd.
Counterparty overviewOrganizer of the seminar, which aims to promote activity in the pharmaceutical, biotech and healthcare industries, particularly the biotech sector. Other company details: not disclosed
Relationship with the CompanyOur Representative Director will speak at the seminar hosted by the other party. Capital, personnel and business relationships: not disclosed
Offering priceFree of charge
Launch dateScheduled for 8 July 2026 (speaking time: 18:50–19:15)
Applicable areaPharmaceutical, biotech and healthcare industries, particularly the biotech sector
LocationFujisawa, Kanagawa Prefecture (the company's head office)
Items this document does not state (10)
Contract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To announce the Representative Director’s participation in the seminar, which will be held to promote activity in the pharmaceutical, biotech and healthcare industries, particularly the biotech sector.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Speaking at the 4th Joint Seminar on Pharmaceuticals, Biotechnology and Healthcare | Chordia Therapeutics Inc. (190A) timely disclosure | Komori